Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study.
about
Induction of remission in a patient with Takayasu's arteritis by low dose pulses of methotrexate.Alternative strategies in the treatment of bronchial asthma.Methotrexate as a steroid sparing agent for asthma in adults.Intramuscular high-dose triamcinolone acetonide in the treatment of severe chronic asthmaWeekly low-dose methotrexate for reduction of Global Initiative for Asthma Step 5 treatment in severe refractory asthma: study protocol for a randomized controlled trialIssues and advances in the pharmacotherapy of asthma.Alternative therapy in severe asthma.Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammationMethotrexate as an oral corticosteroid-sparing agent in severe asthma: the emergence of a responder asthma endotype.Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.Alternative treatments for asthma: assessing the need.Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesRationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids.Therapeutic progress--review XXXVII. Methotrexate--an immunomodulator with expanding indications.Treating patients with asthma who are dependent on systemic steroidsCorticosteroid sparing agents in asthma.Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.Current management of asthma patients with corticosteroid resistance.New insights into the pathogenesis and management of steroid-resistant asthma.Treatment of chronic severe asthma.Clinical pharmacology and therapeutics.Treatment of asthma. New and time-tested strategies.Impact of free magnolol excretions in asthmatic patients who responded well to saiboku-to, a Chinese herbal medicine.Asthma and autoimmunity: a complex but intriguing relation.
P2860
Q33564888-C898F70F-F012-4DBE-B906-2414A9F38898Q33801225-F181EFD1-DBB5-43B3-ACF0-A7774E99EF97Q33908764-3895CA5F-B252-4D86-9D11-35898F883B05Q34187193-C7513793-8836-481D-B72B-60390C342641Q34996190-C02647FA-4713-446D-9F89-B91381016A73Q35273673-DA5F3895-1E38-4362-9E5C-B099EF08E651Q35901966-36224FCB-DBF9-4D74-AAF3-72435FC02F24Q35987351-C41BA652-8AA7-41A5-BF10-2A7C40D5E353Q36239295-480E1538-93B3-49AB-A4CF-1B0D65554B75Q36241367-323755EA-7204-4DA1-9CFB-AD0D0F2F95DBQ36362318-DCF9797A-5AB2-46CE-867B-A9A3BFFF492BQ36724093-D60F6B1F-FB75-4068-913B-1307791CC7AEQ37901553-E2E02778-5A59-42C4-9FF8-5B0EAA6BDE11Q37924091-F5B0A01D-569F-4392-B84B-871D8A9CD80AQ38231903-850DD43D-2FDA-49B8-937D-421F152E560AQ40436152-6AB5E46B-ECB8-4367-B0A1-7CEF0291C030Q40742086-842F57B1-54AD-4A6C-9E7C-B2A101817E2EQ41075227-4FA188D1-0D62-4038-A291-BEB7FE0E2B20Q41486524-45E58A5E-1A98-4B39-93BC-16E692C79D9DQ43124382-238E2A78-94AD-4C57-9707-E477309B4C1BQ43263960-310FCB41-971C-4E93-9D82-F4308CEDD6ABQ46114062-4A161949-AA90-4A2B-91FE-A650F2F509EFQ47255015-1E157831-2A1A-4D46-81FA-9C6D99B80474Q51676365-819CC6C9-FF0D-4E5A-8B22-3B87D9FF6237
P2860
Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Methotrexate in the treatment ...... double-blind crossover study.
@en
Methotrexate in the treatment ...... double-blind crossover study.
@nl
type
label
Methotrexate in the treatment ...... double-blind crossover study.
@en
Methotrexate in the treatment ...... double-blind crossover study.
@nl
prefLabel
Methotrexate in the treatment ...... double-blind crossover study.
@en
Methotrexate in the treatment ...... double-blind crossover study.
@nl
P2093
P1476
Methotrexate in the treatment ...... double-blind crossover study.
@en
P2093
Andrade WP
Blumenstein BA
Mullarkey MF
P304
P356
10.1056/NEJM198803103181004
P407
P577
1988-03-01T00:00:00Z